This is a Swiss company engaged in the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. It combined with Helix Acquisition Corp in April 2022.
This is a Swiss company engaged in the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. It combined with Helix Acquisition Corp in April 2022.